MedPath

The comparative study of the impact of differences in the timing of oral metformin hydrochloride in type 2 diabetes is on the glycemic control.

Not Applicable
Conditions
Diabetes
Registration Number
JPRN-UMIN000018271
Lead Sponsor
Kyoto Prefectural University of Medicine, Graduate School of Medical Science
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
6
Inclusion Criteria

Not provided

Exclusion Criteria

What you are using three or more agents of oral hypoglycemic agents other than metformin formulation.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath